Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

Complex PCI among older patients linked to increased risk of death

“Given the dramatic difference in death risk for older adults receiving complex PCI, we suggest that such interventions in this exceptionally vulnerable population should be approached with additional caution," researchers wrote. 

Cardiologist compensation much higher at hospitals and health systems than private practices—and the gap is widening

A new 57-page report from MedAxiom explored the latest data on compensation, production, staffing and medical imaging offerings among cardiology programs in the United States. 

AI artificial intelligence stethoscope doctor

FDA clears AI model for detecting signs of heart failure in ECGs

The advanced AI model, developed by Anumana with help from Mayo Clinic, could provide value as a screening tool for heart failure.

money business cash flow dollar

Cordis finalizes deal to acquire MedAlliance for up to $1.1B

The total value of the acquisition, first announced in 2022, is dependent on various regulatory and commercial milestones.

cannabis use disorder marijuana joint weed smoking

Excessive cannabis use linked to greater risk of heart attack, other cardiovascular events

Researchers examined data from nearly 60,000 adults, focusing on individuals who have been diagnosed with Cannabis Use Disorder. 

Death after TAVR: Heart failure, sudden cardiac arrest stand out as 2 leading causes

A majority of patient deaths within two years of TAVR can be linked to cardiovascular complications, according to new research published in JACC: Cardiovascular Interventions. Can follow-up care be improved to combat this trend? 

Masking, social distancing ‘do not reduce and may enhance’ subjective well-being in the pandemic-wary

Regardless of effectiveness or lack thereof, pandemic-response measures like masking and social distancing give many people a sense of being better off with them than without them. 

Merck is seeking FDA approval for sotatercept to be used as a treatment for pulmonary arterial hypertension

FDA grants speedy review to Merck's new drug for pulmonary arterial hypertension

The FDA is expected to base its decision in part on the STELLAR clinical trial, which included 163 adult patients treated with subcutaneous sotatercept and 160 patients treated with a placebo.